Things We Do for No Reason™: Avoiding intravenous iodinated contrast material in patients with acute kidney injury or chronic kidney disease.
Offers crucial evidence on the cardio-renal benefits of dual GIP/GLP-1 receptor agonists in patients with diabetic kidney disease.
More from ASNRT News
Browse the latest news, society announcements, KDIGO guideline updates, and AJNT issue releases on the ASNRT newsroom.
All news · ASNRT home